Antibodies under a microscope

Ab02127-10.3

Anti-Neuroligin-3 [N110/29.4], Human IgG1, Fc Silent™, kappa

Description

Recombinant monoclonal antibody to Neuroligin-3. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma N110/29.4. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Target

Neuroligin-3

Target Alias Names

N110/29.4R, Gliotactin homolog, N110/29, S110-29

Isotype/Mimetic

IgG1

Animal-Derived Biomaterials Used

No

Sequence Available

No

Original Discovery Method

recombinantly reformatted hybridoma (from pre-2020 immunisation)

Original Discovery Information Provided On Datasheet

Yes

Antibody/Binder Origins

Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression